Schulman, M.P.: " Purines and Pyrimidines ," in Greenberg, D.M.: Metabolic Pathways , New York: Academic Press, Inc., 1961;, vol 2, pp 389-467.
Smith, L.H., Jr., and Baker, F.A.: Pyrimidine Metabolism in Man: I. The Biosynthesis of Orotic Acid , J Clin Invest 38:798-809 (
(May)
) 1959;.
Adler, M., and Gutman, A.B.: A Uridine Isomer (5-Ribosyluracil) in Human Urine , Science 130:862-863 (
(Oct 2)
) 1959;.
Adams, M.J.; Davis, T.; and Nakatani, N.: Purine and Pyrimidine Metabolism in Normal and Leukemic Subjects , Amer J Med 28:726-734 (
(May)
) 1960;.
Cohn, W.E.: Pseudouridine, a Carbon-Carbon Linked Ribonucleoside in Ribonucleic Acid: Isolation, Structure and Chemical Characteristics , J Biol Chem 235:1488-1498 (
(May)
) 1960;.
Weissman, S.M., et al: Pseudouridine Metabolism: III. Studies With Isotopically Labelled Pseudouridine , J Lab Clin Med 60:40-47 (
(July)
) 1962;
Weiss, S.B, and Legault-Demare, J.: Pseudouridine Formation: Evidence for RNA as an Intermediate , Science 149:429-431 (
(July 23)
) 1965;.
Weissman, S.M., et al: The Metabolism of Ring-Labelled Orotic Acid in Man , J Clin Invest 41:1546-1552 (
(July)
) 1962;.
Weissman, S.M.; Lewis, M.; and Karon. M.: The Metabolism of Isotopically Labelled Uracil and Uridine in Man , Metabolism 12:60-67 (
(Jan)
) 1963;.
Weissman, S.M.; Eisen, A.Z.; and Karon, M.: Pseudouridine Metabolism: II. Excretion in Various Disease States , J Lab Clin Med 59:852-858 (
(May)
) 1962;.
Weissman, S.M.; Lewis, M.; and Karon, M.: Pseudouridine Metabolism: IV. Excretion of Pseudouridine and Other Nitrogenous Metabolites in Chronic Leukemia , Blood 22:657-663 (
(Dec)
) 1963;.
Lewis, M.; Weissman, S.M.; and Karon, M.: Studies on the Pseudouridinia of Chronic Lymphatic Leukemia , Blood 24:567-576 (
(Nov)
) 1964;.
Huguley, C.M., Jr., et al: Refractory Megaloblastic Anemia Associated With Excretion of Orotic Acid , Blood 14:615-634 (
(June)
) 1959;.
Becroft, D.M.O., and Phillips, L.I.: Hereditary Orotic Aciduria and Megaloblastic Anemia: A Second Case With Response to Uridine , Brit Med J 1:547-552 (
(Feb 27)
) 1965;.
Smith, L.H., Jr.; Huguley, C.M., Jr.; and Bain, J.A. in Stanbury, J.B.; Wyngaarden, J.B.; and Frederickson, D.S. (eds.): The Metabolic Basis of Inherited Disease , New York: McGraw-Hill Book Co., Inc.. 1964;.
Smith, L.H.. Jr.; Sullivan, M.; and Huguley, C.M.: Pyrimidine Metabolism in Man: IV. The Enzymatic Defect of Orotic Aciduria , J Clin Invest 40:656-664 (
(April)
) 1961;.
Smith, L.H., Jr.: Hereditary Orotic Aciduria-Pyrimidine Auxotrophism in Man , Amer J Med 38:1-6 (
(Jan)
) 1965;.
Handschumacher, R.E., et al: Summary of Current Information on 6-Azauridine , Cancer Chemother Rep 21:1-18 (
(Aug)
) 1962;.
Fallon, H.J. et al: The Uricosuria and Orotic Aciduria Induced by 6-Azauridine , J Clin Invest 40:1906-1914 (
(Oct)
) 1961;.
Buttoo, A.S; Israels, M.C.G.; and Wilkinson, J.F.: Hypocholesterolemia and Orotic Aciduria During Treatment With 6-Azauridine , Brit Med J 1:552-554 (
(Feb 27)
) 1965;.
Handschumacher, R.E., and Welch, A.D.: " Antimetabolites and Nucleic Acid Metabolism: V. Structural Analogs of Pyrimidines and Their Effects on Nucleic Acid Metabolism ," in Chorgoff, E.. and Davidson, J.N.: The Nucleic Acids , New York: Academic Press, Inc., 1960;, pp 498-506.
Zubrod, C.G.: " The Limited Usefulness of 5-Fluorourial (5-FU) and 5-Fluorodeoxyuridine (5-FUDR) in the Management of Patients With Adenocarcinomas ," in Ingelfinger, F. (ed.): Controversy in Internal Medicine , Philadelphia: W.B. Saunders, Co., to be published.